We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

87 hedge funds and large institutions have $9.38M invested in Vaxart in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,291% more call options, than puts

Call options by funds: $153K | Put options by funds: $11K

5% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 21

1.43% less ownership

Funds ownership: 12.16% → 10.73% (-1.4%)

9% less funds holding

Funds holding: 96 → 87 (-9)

33% less capital invested

Capital invested by funds: $13.9M → $9.38M (-$4.56M)

56% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 16

Holders
87
Holders Change
-9
Holders Change %
-9.38%
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
22
Reduced
21
Closed
16
Calls
$153K
Puts
$11K
Net Calls
+$142K
Net Calls Change
-$59K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$341K
2
CCM
Connective Capital Management
California
+$268K
3
GCP
GSA Capital Partners
United Kingdom
+$142K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$121K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$67K

Top Sellers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
-$1.36M
2
Millennium Management
Millennium Management
New York
-$970K
3
Charles Schwab
Charles Schwab
California
-$111K
4
Two Sigma Investments
Two Sigma Investments
New York
-$61.4K
5
Invesco
Invesco
Georgia
-$30.3K

VXRT Hedge Fund Activity: Q4 2023 in Review

87 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2023, worth a combined $9.38M — down 33% from $13.9M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of VXRT and 7 opened new positions — a net loss of 9 holders — while 21 trimmed existing stakes and 22 added.

The largest buyer was Citadel Advisors, adding an estimated $341K. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $1.36M sold.

  • 87 institutional investors held Vaxart (VXRT) as of Q4 2023, down from 96 in Q3 2023.
  • Funds reported $9.38M of Vaxart stock for Q4 2023, down 33% quarter-over-quarter.
  • 7 funds opened new Vaxart positions in Q4 2023 and 16 closed out, a net change of -9 holders.
  • The largest Vaxart buyer in Q4 2023 was Citadel Advisors, an estimated $341K added.
  • The largest Vaxart seller in Q4 2023 was Cantor Fitzgerald, an estimated $1.36M sold.

Based on aggregated 13F filings for Q4 2023.